Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Istanbul - Delayed Quote TRY

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (MEDTR.IS)

31.50
-0.30
(-0.94%)
At close: 6:09:46 PM GMT+3
Loading Chart for MEDTR.IS
  • Previous Close 31.80
  • Open 31.68
  • Bid 31.48 x --
  • Ask 31.56 x --
  • Day's Range 31.32 - 31.94
  • 52 Week Range 29.72 - 55.00
  • Volume 378,855
  • Avg. Volume 445,124
  • Market Cap (intraday) 3.748B
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 50.81
  • EPS (TTM) 0.62
  • Earnings Date --
  • Forward Dividend & Yield 0.25 (0.79%)
  • Ex-Dividend Date Jul 28, 2025
  • 1y Target Est 68.90

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers breathing sytems products, including breathing circuits, breathing filters, catheter mounts, gas sampling lines, accessories, masks, and connectors. It also provides hospital products, such as barrier cream, surgical hand brushes for skin disinfection, hand and skin antiseptics, and skin and mucosa antiseptics. In addition, the company engages in the manufacturing and sale of anesthesia and intensive care circuits; installation, operation, and design of oncology drug preparation and delivery systems; production, sales, and technical service of infusion pumps and sets; and manufacturing of biocidal products. It also exports its products to 80 countries under its Altech brand name. Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi was founded in 1983 and is headquartered in Izmir, Turkey.

www.meditera.com.tr

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MEDTR.IS

View More

Performance Overview: MEDTR.IS

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is BIST 100 (XU100.IS) .

YTD Return

MEDTR.IS
40.45%
BIST 100 (XU100.IS)
7.65%

1-Year Return

MEDTR.IS
0.64%
BIST 100 (XU100.IS)
9.63%

3-Year Return

MEDTR.IS
161.03%
BIST 100 (XU100.IS)
273.51%

5-Year Return

MEDTR.IS
257.95%
BIST 100 (XU100.IS)
91.02%

Compare To: MEDTR.IS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MEDTR.IS

View More

Valuation Measures

Annual
As of 4/29/2025
  • Market Cap

    3.78B

  • Enterprise Value

    3.40B

  • Trailing P/E

    51.29

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.81

  • Price/Book (mrq)

    1.70

  • Enterprise Value/Revenue

    1.62

  • Enterprise Value/EBITDA

    14.48

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.51%

  • Return on Assets (ttm)

    5.24%

  • Return on Equity (ttm)

    3.22%

  • Revenue (ttm)

    2.09B

  • Net Income Avi to Common (ttm)

    73.43M

  • Diluted EPS (ttm)

    0.62

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    434.09M

  • Total Debt/Equity (mrq)

    2.10%

  • Levered Free Cash Flow (ttm)

    -106.23M

Research Analysis: MEDTR.IS

View More

Company Insights: MEDTR.IS

Research Reports: MEDTR.IS

View More

People Also Watch